Morten Herholdt
Stock Analyst at HSBC
(1.35)
# 3,308
Out of 4,711 analysts
17
Total ratings
33.33%
Success rate
-6.99%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $228.61 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $164.84 | +36.50% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $146.47 | +133.49% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $92.57 | -25.46% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $144.47 | +17.67% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $8.50 | +140.00% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $500.13 | +7.97% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $47.59 | +9.27% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $197.27 | +31.80% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $263.38 | +21.50% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.29 | +799.22% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $228.61
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $164.84
Upside: +36.50%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $146.47
Upside: +133.49%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $92.57
Upside: -25.46%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $144.47
Upside: +17.67%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $8.50
Upside: +140.00%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $500.13
Upside: +7.97%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $47.59
Upside: +9.27%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $197.27
Upside: +31.80%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $263.38
Upside: +21.50%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.29
Upside: +799.22%